| Allison Janai Higginbotham, DO | |
|
3901 Lone Tree Way Ste 211, Antioch, CA 94509-6200 | |
| (925) 756-1192 | |
| (925) 779-7220 |
| Full Name | Allison Janai Higginbotham |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Location | 3901 Lone Tree Way Ste 211, Antioch, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306233515 | NPI | - | NPPES |
| 20A15957 | Other | CA | STATE MEDICAL LICENSE |
| Entity Name | Permanente Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
July 3 was the quiet afternoon that a deputy assistant Treasury secretary for tax policy announced in a blog post that the Affordable Care Act's employer mandate would be delayed one year. Something about the "complexity of the requirements." ... Even if you are a liberal and support the goals of the Affordable Care Act, there has to be an emerging sense that maybe the law's theorists missed a signal from life outside the castle walls. While they troweled brick after brick into a 2,000-page law, the rest of the world was reshaping itself into smaller, more nimble units whose defining metaphor is the 140-character Twitter message (Daniel Henninger, 7/10).
After 45 days in NASA's Human Exploration Research Analog (HERA), the four-man crew can hardly hold their eyes open. This mission was the first of its kind to last 45 days, as well as incorporate sleep reduction for research purposes.
When a person is sick, there is a tell-tale sign in their blood: a different mix of the various types of immune cells called leukocytes. A group of scientists at several institutions including Brown University has discovered a way to determine that mix from the DNA in archival or fresh blood samples, potentially providing a practical new technology not only for medical research but also for clinical diagnosis and treatment monitoring of ailments including some cancers.
Metabolex, Inc., a biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases, announced positive results from two multiple ascending dose Phase 1 clinical trials of MBX-2982.
› Verified 2 days ago
| Entity Name | Sutter Bay Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013950807 PECOS PAC ID: 4284538778 Enrollment ID: O20031125000909 |
News Archive
July 3 was the quiet afternoon that a deputy assistant Treasury secretary for tax policy announced in a blog post that the Affordable Care Act's employer mandate would be delayed one year. Something about the "complexity of the requirements." ... Even if you are a liberal and support the goals of the Affordable Care Act, there has to be an emerging sense that maybe the law's theorists missed a signal from life outside the castle walls. While they troweled brick after brick into a 2,000-page law, the rest of the world was reshaping itself into smaller, more nimble units whose defining metaphor is the 140-character Twitter message (Daniel Henninger, 7/10).
After 45 days in NASA's Human Exploration Research Analog (HERA), the four-man crew can hardly hold their eyes open. This mission was the first of its kind to last 45 days, as well as incorporate sleep reduction for research purposes.
When a person is sick, there is a tell-tale sign in their blood: a different mix of the various types of immune cells called leukocytes. A group of scientists at several institutions including Brown University has discovered a way to determine that mix from the DNA in archival or fresh blood samples, potentially providing a practical new technology not only for medical research but also for clinical diagnosis and treatment monitoring of ailments including some cancers.
Metabolex, Inc., a biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases, announced positive results from two multiple ascending dose Phase 1 clinical trials of MBX-2982.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Allison Janai Higginbotham, DO 325 Distel Cir, Los Altos, CA 94022-1408 Ph: (925) 756-1192 | Allison Janai Higginbotham, DO 3901 Lone Tree Way Ste 211, Antioch, CA 94509-6200 Ph: (925) 756-1192 |
News Archive
July 3 was the quiet afternoon that a deputy assistant Treasury secretary for tax policy announced in a blog post that the Affordable Care Act's employer mandate would be delayed one year. Something about the "complexity of the requirements." ... Even if you are a liberal and support the goals of the Affordable Care Act, there has to be an emerging sense that maybe the law's theorists missed a signal from life outside the castle walls. While they troweled brick after brick into a 2,000-page law, the rest of the world was reshaping itself into smaller, more nimble units whose defining metaphor is the 140-character Twitter message (Daniel Henninger, 7/10).
After 45 days in NASA's Human Exploration Research Analog (HERA), the four-man crew can hardly hold their eyes open. This mission was the first of its kind to last 45 days, as well as incorporate sleep reduction for research purposes.
When a person is sick, there is a tell-tale sign in their blood: a different mix of the various types of immune cells called leukocytes. A group of scientists at several institutions including Brown University has discovered a way to determine that mix from the DNA in archival or fresh blood samples, potentially providing a practical new technology not only for medical research but also for clinical diagnosis and treatment monitoring of ailments including some cancers.
Metabolex, Inc., a biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases, announced positive results from two multiple ascending dose Phase 1 clinical trials of MBX-2982.
› Verified 2 days ago
Dr. James Francis Chan, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4501 Sand Creek Rd, Antioch, CA 94531 Phone: 925-813-6500 Fax: 925-813-7411 | |
Rohee Krishan, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3901 Lone Tree Way, Antioch, CA 94509 Phone: 925-779-7200 | |
Ni Mo, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4501 Sand Creek Rd, Antioch, CA 94531 Phone: 925-813-6500 | |
Adedotun A Adewusi, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3901 Lone Tree Way, Antioch, CA 94509 Phone: 925-756-1192 Fax: 925-779-7220 | |
Jingping Hao, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4501 Sand Creek Rd, Antioch, CA 94531 Phone: 925-813-6500 | |
Virginia Kathleen Scialanca, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3901 Lone Tree Way, Antioch, CA 94509 Phone: 925-779-7200 | |
Lenny Husen, M.D Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3901 Lone Tree Way, Antioch, CA 94509 Phone: 925-779-7200 |